Cargando…
Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors
Fulminant myocarditis (FM) may lead to cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Results of effectiveness studies of VA-ECMO have been contradictory. We evaluated the aggregate short-term mortality after VA-ECMO and predictive factors in patients with F...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540286/ https://www.ncbi.nlm.nih.gov/pubmed/36205853 http://dx.doi.org/10.1007/s10741-022-10277-z |
_version_ | 1784803678252695552 |
---|---|
author | Vishram-Nielsen, Julie K. K. Foroutan, Farid Rizwan, Saima Peck, Serena S. Bodack, Julia Orchanian-Cheff, Ani Gustafsson, Finn Ross, Heather J. Fan, Eddy Rao, Vivek Billia, Filio Alba, Ana Carolina |
author_facet | Vishram-Nielsen, Julie K. K. Foroutan, Farid Rizwan, Saima Peck, Serena S. Bodack, Julia Orchanian-Cheff, Ani Gustafsson, Finn Ross, Heather J. Fan, Eddy Rao, Vivek Billia, Filio Alba, Ana Carolina |
author_sort | Vishram-Nielsen, Julie K. K. |
collection | PubMed |
description | Fulminant myocarditis (FM) may lead to cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Results of effectiveness studies of VA-ECMO have been contradictory. We evaluated the aggregate short-term mortality after VA-ECMO and predictive factors in patients with FM. We systematically searched in electronic databases (February 2022) to identify studies evaluating short-term mortality (defined as mortality at 30 days or in-hospital) after VA-ECMO support for FM. We included studies with 5 or more patients published after 2009. We assessed the quality of the evidence using the QUIPS and GRADE tools. Mortality was pooled using random effect models. We performed meta-regression to explore heterogeneity based on a priori defined factors. We included 54 observational studies encompassing 2388 FM patients supported with VA-ECMO. Median age was 41 years (25th to 75th percentile 37–47), and 50% were female. The pooled short-term mortality was 35% (95% CI 29–40%, I(2) = 69%; moderate certainty). By meta-regression, studies with younger populations showed lower mortality. Female sex, receiving a biopsy, cardiac arrest, left ventricular unloading, and earlier recruitment time frame, did not explain heterogeneity. These results remained consistent regardless of continent and the risk of bias category. In individual studies, low pH value, high lactate, absence of functional cardiac recovery on ECMO, increased burden of malignant arrhythmia, high peak coronary markers, and IVIG use were identified as independent predictors of mortality. When conventional therapies have failed, especially in younger patients, cardiopulmonary support with VA-ECMO should be considered in the treatment of severe FM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10741-022-10277-z. |
format | Online Article Text |
id | pubmed-9540286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-95402862022-10-11 Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors Vishram-Nielsen, Julie K. K. Foroutan, Farid Rizwan, Saima Peck, Serena S. Bodack, Julia Orchanian-Cheff, Ani Gustafsson, Finn Ross, Heather J. Fan, Eddy Rao, Vivek Billia, Filio Alba, Ana Carolina Heart Fail Rev Article Fulminant myocarditis (FM) may lead to cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Results of effectiveness studies of VA-ECMO have been contradictory. We evaluated the aggregate short-term mortality after VA-ECMO and predictive factors in patients with FM. We systematically searched in electronic databases (February 2022) to identify studies evaluating short-term mortality (defined as mortality at 30 days or in-hospital) after VA-ECMO support for FM. We included studies with 5 or more patients published after 2009. We assessed the quality of the evidence using the QUIPS and GRADE tools. Mortality was pooled using random effect models. We performed meta-regression to explore heterogeneity based on a priori defined factors. We included 54 observational studies encompassing 2388 FM patients supported with VA-ECMO. Median age was 41 years (25th to 75th percentile 37–47), and 50% were female. The pooled short-term mortality was 35% (95% CI 29–40%, I(2) = 69%; moderate certainty). By meta-regression, studies with younger populations showed lower mortality. Female sex, receiving a biopsy, cardiac arrest, left ventricular unloading, and earlier recruitment time frame, did not explain heterogeneity. These results remained consistent regardless of continent and the risk of bias category. In individual studies, low pH value, high lactate, absence of functional cardiac recovery on ECMO, increased burden of malignant arrhythmia, high peak coronary markers, and IVIG use were identified as independent predictors of mortality. When conventional therapies have failed, especially in younger patients, cardiopulmonary support with VA-ECMO should be considered in the treatment of severe FM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10741-022-10277-z. Springer US 2022-10-07 2023 /pmc/articles/PMC9540286/ /pubmed/36205853 http://dx.doi.org/10.1007/s10741-022-10277-z Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Vishram-Nielsen, Julie K. K. Foroutan, Farid Rizwan, Saima Peck, Serena S. Bodack, Julia Orchanian-Cheff, Ani Gustafsson, Finn Ross, Heather J. Fan, Eddy Rao, Vivek Billia, Filio Alba, Ana Carolina Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors |
title | Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors |
title_full | Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors |
title_fullStr | Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors |
title_full_unstemmed | Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors |
title_short | Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors |
title_sort | patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540286/ https://www.ncbi.nlm.nih.gov/pubmed/36205853 http://dx.doi.org/10.1007/s10741-022-10277-z |
work_keys_str_mv | AT vishramnielsenjuliekk patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors AT foroutanfarid patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors AT rizwansaima patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors AT peckserenas patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors AT bodackjulia patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors AT orchaniancheffani patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors AT gustafssonfinn patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors AT rossheatherj patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors AT faneddy patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors AT raovivek patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors AT billiafilio patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors AT albaanacarolina patientswithfulminantmyocarditissupportedwithvenoarterialextracorporealmembraneoxygenationasystematicreviewandmetaanalysisofshorttermmortalityandimpactofriskfactors |